PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding PDS Biotechnology Corp changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 60 | 1 | 66 | +7 |
| Shares | 6.78M | 116.7K | 5.97M | −693.2K (−10.4%) |
| Value | $101.0M | $1.74M | $48.3M | −$50.9M (−51.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held PDS Biotechnology Corp at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 91,770 | $743.0K | 0.00% |
| Sassicaia Capital Advisers LLC | 75,200 | $609.0K | 4.20% |
| Dimensional Fund Advisors LP | 34,831 | $282.0K | 0.00% |
| HRT Financial LP | 34,786 | $281.0K | 0.00% |
| Qube Research & Technologies Ltd | 34,543 | $280.0K | 0.00% |
| Alps Advisors Inc | 32,906 | $267.0K | 0.00% |
| Alpine Global Management, LLC | 32,425 | $263.0K | 0.04% |
| D. E. Shaw & Co., Inc. | 29,605 | $240.0K | 0.00% |
| Old Mission Capital LLC | 20,839 | $169.0K | 0.01% |
| Balyasny Asset Management LLC | 15,802 | $128.0K | 0.00% |
| Ergoteles LLC | 15,000 | $122.0K | 0.00% |
| Boulder Hill Capital Management LP | 15,100 | $122.0K | 0.12% |
| Ikarian Capital, LLC | 3,495 | $28.0K | 0.01% |
| The PNC Financial Services Group, Inc. | 1,000 | $8.00K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $8.00K | 0.00% |
| National Bank of Canada | 600 | $5.00K | 0.00% |
| Royal Bank of Canada | 505 | $4.00K | 0.00% |
| Horan Securities, Inc. | 470 | $4.00K | 0.00% |
| Lindbrook Capital, LLC | 500 | $4.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 43 | $0 | 0.00% |
Sold out (13)
Institutions that held PDS Biotechnology Corp at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Invesco Ltd. | 329,698 | $4.91M |
| EAM Investors, LLC | 258,769 | $3.86M |
| EAM Global Investors LLC | 158,637 | $2.36M |
| Voloridge Investment Management, LLC | 49,191 | $733.0K |
| LPL Financial LLC | 45,436 | $677.0K |
| Virtu Financial LLC | 17,696 | $264.0K |
| Andesa Financial Management Inc. | 16,655 | $248.0K |
| Barclays PLC | 14,728 | $219.0K |
| Ground Swell Capital, LLC | 11,517 | $172.0K |
| Brewin Dolphin Ltd | 6,150 | $91.6K |
| Dorsey Wright & Associates | 4,425 | $66.0K |
| UBS Group AG | 2,946 | $44.0K |
| Arkadios Wealth Advisors | 500 | $7.00K |
Not filed for Q4 2021 yet (1)
Institutions that held PDS Biotechnology Corp at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 116,677 | $1.74M |